Filing Details

Accession Number:
0001225208-16-038312
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-08-24 16:47:46
Reporting Period:
2016-08-23
Filing Date:
2016-08-24
Accepted Time:
2016-08-24 16:47:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1099800 Edwards Lifesciences Corp EW Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 364316614
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1308771 B Patrick Verguet One Edwards Way
Irvine CA 92614
Cvp, Europe No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-08-23 10,000 $25.48 138,998 No 4 M Direct
Common Stock Disposition 2016-08-23 92 $117.16 138,906 No 4 S Direct
Common Stock Disposition 2016-08-23 10,000 $117.54 128,906 No 4 S Direct
Common Stock Acquisiton 2016-08-24 5,000 $25.48 133,906 No 4 M Direct
Common Stock Disposition 2016-08-24 5,000 $116.81 128,906 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Acquire) Disposition 2016-08-23 10,000 $0.00 10,000 $25.48
Common Stock Employee Stock Option (Right to Acquire) Disposition 2016-08-24 5,000 $0.00 5,000 $25.48
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
58,000 2011-05-13 2017-05-12 No 4 M Direct
53,000 2011-05-13 2017-05-12 No 4 M Direct
Footnotes
  1. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.
  2. This transaction was executed in multiple trades at prices ranging from $117.50 to $117.64. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.